5-Bromo-4-propylpyrimidine

Catalog No.: 
ACLWZE314
CAS No.: 
951884-26-7
Molecular Formula: 
C7H9BrN2
Molecular Weight: 
201.07
5-Bromo-4-propylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$165.00InquiryInquiry
5g98%$475.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-propylpyrimidine
IUPAC Name5-bromo-4-propylpyrimidine
MDL No.B188593
Molecular FormulaC7H9BrN2
Molecular Weight201.07
SMILESCCCC1=NC=NC=C1Br
InChI KeyCTQOACFKRRAZGP-UHFFFAOYSA-N
Synonym5-Bromo-4-propylpyrimidine | 951884-26-7 | 5-bromo-4-propyl-pyrimidine | DTXSID70650031 | BNB88426 | MFCD09800929 | AKOS015834354 | PS-3473 | SB58315 | EN300-1273379 | A845215 | J-517113
CAS No.951884-26-7
PubChem CID26369987

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLWZE314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKYVB839 route compound structure diagram
    ACKYVB83956181-39-6In Stock
  4. Then
  5. ACLWZE314 route product structure diagram
    ACLWZE314951884-26-7
Inquiry

2. ACLWZE314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKYVB839 route compound structure diagram
    ACKYVB83956181-39-6In Stock
  4. Then
  5. ACLWZE314 route product structure diagram
    ACLWZE314951884-26-7
Inquiry

3. ACLWZE314 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLWZE314 route product structure diagram
    ACLWZE314951884-26-7
Inquiry

Comments (0)